By combing through the electronic medical records of nearly all of Maine's 1.3 million residents and applying sophisticated modeling software, a computerized tool predicts which patients are most likely to land in the ER
Jessica Taylor’s computer knew her patient was in trouble before she did. Even the patient, a Bangor-area man with chronic illness, was in the dark.
In all likelihood, he was about to wind up in the emergency room.
Taylor, a nurse care manager at St. Joseph Internal Medicine, spotted the warning signs with help from new technology believed to be the first of its kind in the country.
By combing through the electronic medical records of nearly all of Maine’s 1.3 million residents and applying sophisticated modeling software, the computerized tool predicts which patients are most likely to land in the ER. Not only that, but also who is headed for a hospital admission or even well on their way toward a stroke, heart attack or type 2 diabetes.
Read more: http://bit.ly/1LED0hT
Source: Bangor Daily News
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More